Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing...
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing...
SIOUX FALLS SD / ACCESS Newswire / September 16, 2025 / Avel eCare is proud to join healthcare organizations nationwide...
Honors IMF NLB Member Dr. Beth Faiman as First Recipient During the Inauguration and Awards CeremonyCLEVELAND, Ohio, Sept. 16, 2025...
SOUTHLAKE, TX AND AUSTIN, TX / ACCESS Newswire / September 16, 2025 / Allied OMS, the nation's leading doctor-owned and...
MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA...
MOUNTAIN VIEW, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced the seamless integration...
The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL...
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational ImprovementsWILMINGTON, Del., Sept....
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response...
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response...
Arbli™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing...
Arbli™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing...
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF)...
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF)...
Industry veteran brings proven expertise in global clinical development and further strengthens company focus on operational excellence, quality and deliveryRALEIGH,...
Industry veteran brings proven expertise in global clinical development and further strengthens company focus on operational excellence, quality and deliveryRALEIGH,...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comPHOENIX and LONDON, Sept....
AI-first platform transforms recruitment delays into instant enrollments by matching, engaging and enrolling patients in clinical trials.KANSAS CITY, Mo.--(BUSINESS WIRE)--Trially®,...
- Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives...
BUCHAREST, Romania, Sept. 16, 2025 /PRNewswire/ -- Bucharest hosted an important visit this week, as IMPROVATE organized a high-level Israeli medical technology...